1 January 2025 v2026.24.1 limited_company_frs_102_section_1a_v1_1_3 companies_houseSoftwarefalsetruetruetrueNo description of principal activity0falsetruexbrli:purexbrli:sharesiso4217:GBP066742352025-01-012025-12-31066742352025-12-31066742352024-12-3106674235core:WithinOneYear2025-12-3106674235core:WithinOneYear2024-12-3106674235core:ShareCapital2025-12-3106674235core:ShareCapital2024-12-3106674235core:RetainedEarningsAccumulatedLosses2025-12-3106674235core:RetainedEarningsAccumulatedLosses2024-12-3106674235bus:Director12025-01-012025-12-3106674235bus:RegisteredOffice2025-01-012025-12-3106674235core:PlantMachinery2025-01-012025-12-3106674235core:OfficeEquipment2025-01-012025-12-3106674235core:PlantMachinery2025-01-0106674235core:PlantMachinery2025-12-3106674235core:PlantMachinery2024-12-310667423512025-01-012025-12-31066742352024-01-012024-12-3106674235countries:EnglandWales2025-01-012025-12-3106674235bus:AuditExemptWithAccountantsReport2025-01-012025-12-3106674235bus:PrivateLimitedCompanyLtd2025-01-012025-12-3106674235bus:SmallEntities2025-01-012025-12-3106674235bus:FullAccounts2025-01-012025-12-31
Company registration number:
06674235
ITL HEALTH LIMITED
Unaudited Filleted Financial Statements for the year ended
31 December 2025
G&T Accountancy Services Limited
Chartered Certified Accountants
Unit 1b Denby Dale Business Park, Wakefield Road, Huddersfield, West Yorkshire, HD8 8QH, United Kingdom
ITL HEALTH LIMITED
Report to the board of directors on the preparation of the unaudited statutory financial statements of ITL HEALTH LIMITED
Year ended
31 December 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements
of
ITL HEALTH LIMITED
for the year ended
31 December 2025
which comprise the income statement, statement of financial position and related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/​content/​dam/​ACCA_Global/​Members/​Doc/​rule/​2018-rulebook.pdf.
This report is made solely to the Board of Directors of
ITL HEALTH LIMITED
, as a body, in accordance with the terms of our engagement letter dated 20 April 2026. Our work has been undertaken solely to prepare for your approval the
financial statements
of
ITL HEALTH LIMITED
and state those matters that we have agreed to state to the Board of Directors of
ITL HEALTH LIMITED
, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/​content/​dam/​ACCA_Global/​Technical/​fact/​tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than
ITL HEALTH LIMITED
and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that
ITL HEALTH LIMITED
has kept adequate accounting records and to prepare statutory
financial statements
that give a true and fair view of the assets, liabilities, financial position and loss of
ITL HEALTH LIMITED
. You consider that
ITL HEALTH LIMITED
is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of ITL HEALTH LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
G&T Accountancy Services Limited
Chartered Certified Accountants
Unit 1b Denby Dale Business Park
Wakefield Road
Huddersfield
West Yorkshire
HD8 8QH
United Kingdom
Date:
10 June 2026
ITL HEALTH LIMITED
Statement of Financial Position
31 December 2025
20252024
Note££
Fixed assets    
Tangible assets 5
748
 
883
 
Current assets    
Stocks
152,749
 
84,751
 
Debtors 6
115,826
 
131,715
 
Cash at bank and in hand
58,546
 
43,642
 
327,121
 
260,108
 
Creditors: amounts falling due within one year 7
(469,313
)
(383,235
)
Net current liabilities
(142,192
)
(123,127
)
Total assets less current liabilities (141,444 ) (122,244 )
Provisions for liabilities
(142
)
(168
)
Net liabilities
(141,586
)
(122,412
)
Capital and reserves    
Called up share capital
1
 
1
 
Profit and loss account
(141,587
)
(122,413
)
Shareholders deficit
(141,586
)
(122,412
)
For the year ending
31 December 2025
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
10 June 2026
, and are signed on behalf of the board by:
L Morningstar
Director
Company registration number:
06674235
ITL HEALTH LIMITED
Notes to the Financial Statements
Year ended
31 December 2025

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
Suite 1
,
7th Floor 50 Broadway
,
London
,
SW1H 0BL
, United Kingdom.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Going concern

These accounts have been prepared on the going concern basis, on the understanding that the directors and shareholders will continue to financially support the company during this period.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Plant and machinery
50% Reducing Balance
Office equipment
33% straight line

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is more likely than not that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured on an undiscounted basis at the tax rates that would apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted at the statement of financial position date.

Provisions for liabilities

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

Correction of prior period error

During the year the directors identified an error in the valuation of inventories at 31 December 2024. Closing stock had been overstated by £77,682, resulting in an understatement of cost of sales and an overstatement of profit before taxation by the same amount. The comparative figures have been restated accordingly. The effect of the restatement was to reduce inventories by £77,682, reduce the corporation tax charge by £7,065 and reduce retained earnings at 1 January 2025 by £70,617.

4 Average number of employees

The average number of persons employed by the company during the year was
1
(2024: nil).

5 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 January 2025
15,255
 
Additions
458
 
At
31 December 2025
15,713
 
Depreciation  
At
1 January 2025
14,372
 
Charge
593
 
At
31 December 2025
14,965
 
Carrying amount  
At
31 December 2025
748
 
At 31 December 2024
883
 

6 Debtors

20252024
££
Trade debtors
103,648
 
110,244
 
Other debtors
12,178
 
21,471
 
115,826
 
131,715
 

7 Creditors: amounts falling due within one year

20252024
££
Trade creditors
256,392
 
142,926
 
Amounts owed to group undertakings and undertakings in which the company has a participating interest
156,057
 
171,450
 
Taxation and social security
15,232
 
26,541
 
Other creditors
41,632
 
42,318
 
469,313
 
383,235
 

9 Controlling party

The company was under the control of Ms M Esser throughout the current and prior year.